Morbidity and mortality in the antiphospholipid syndrome during a 10-year period: a multicentre prospective study of 1000 patients

R Cervera; R Serrano; G J Pons-Estel; L Ceberio-Hualde; Y Shoenfeld; E de Ramón; V Buonaiuto; Søren Jacobsen; M M Zeher; T Tarr; A Tincani; M Taglietti; G Theodossiades; E Nomikou; M Galeazzi; F Bellisai; P L Meroni; R H W M Derksen; P G D de Groot; M Baleva; M Mosca; S Bombardieri; F Houssiau; J-C Gris; I Quéré; E Hachulla; C Vasconcelos; A Fernández-Nebro; M Haro; Z Amoura; M Miyara; M Tektonidou; G Espinosa; M L Bertolaccini; M A Khamashta; on behalf of the Euro-Phospholipid Project Group (European Forum on Antiphospholipid Antibodies)

doi:10.1136/annrheumdis-2013-204838

Morbidity and mortality in the antiphospholipid syndrome during a 10-year period: a multicentre prospective study of 1000 patients

R Cervera, R Serrano, G J Pons-Estel, L Ceberio-Hualde, Y Shoenfeld, E de Ramón, V Buonaiuto, Søren Jacobsen, M M Zeher, T Tarr, A Tincani, M Taglietti, G Theodossiades, E Nomikou, M Galeazzi, F Bellisai, P L Meroni, R H W M Derksen, P G D de Groot, M BalevaM Mosca, S Bombardieri, F Houssiau, J-C Gris, I Quéré, E Hachulla, C Vasconcelos, A Fernández-Nebro, M Haro, Z Amoura, M Miyara, M Tektonidou, G Espinosa, M L Bertolaccini, M A Khamashta, on behalf of the Euro-Phospholipid Project Group (European Forum on Antiphospholipid Antibodies)

Afdeling for Rygkirurgi, Led- og Bindevævssygdomme HOC

692 Citationer (Scopus)

Abstract

To assess the prevalence of the main causes of morbi-mortality in the antiphospholipid syndrome (APS) during a 10-year-follow-up period and to compare the frequency of early manifestations with those that appeared later.

Originalsprog	Engelsk
Tidsskrift	Annals of the Rheumatic Diseases
Vol/bind	74
Udgave nummer	6
Sider (fra-til)	1011-8
ISSN	0003-4967
DOI	https://doi.org/10.1136/annrheumdis-2013-204838
Status	Udgivet - 2015

Adgang til dokumentet

10.1136/annrheumdis-2013-204838

Andre filer og links

Link to publication in Scopus

Citationsformater

Cervera, R., Serrano, R., Pons-Estel, G. J., Ceberio-Hualde, L., Shoenfeld, Y., de Ramón, E., Buonaiuto, V., Jacobsen, S., Zeher, M. M., Tarr, T., Tincani, A., Taglietti, M., Theodossiades, G., Nomikou, E., Galeazzi, M., Bellisai, F., Meroni, P. L., Derksen, R. H. W. M., de Groot, P. G. D., ... on behalf of the Euro-Phospholipid Project Group (European Forum on Antiphospholipid Antibodies) (2015). Morbidity and mortality in the antiphospholipid syndrome during a 10-year period: a multicentre prospective study of 1000 patients. Annals of the Rheumatic Diseases, 74(6), 1011-8. https://doi.org/10.1136/annrheumdis-2013-204838

Cervera, R, Serrano, R, Pons-Estel, GJ, Ceberio-Hualde, L, Shoenfeld, Y, de Ramón, E, Buonaiuto, V, Jacobsen, S, Zeher, MM, Tarr, T, Tincani, A, Taglietti, M, Theodossiades, G, Nomikou, E, Galeazzi, M, Bellisai, F, Meroni, PL, Derksen, RHWM, de Groot, PGD, Baleva, M, Mosca, M, Bombardieri, S, Houssiau, F, Gris, J-C, Quéré, I, Hachulla, E, Vasconcelos, C, Fernández-Nebro, A, Haro, M, Amoura, Z, Miyara, M, Tektonidou, M, Espinosa, G, Bertolaccini, ML, Khamashta, MA & on behalf of the Euro-Phospholipid Project Group (European Forum on Antiphospholipid Antibodies) 2015, 'Morbidity and mortality in the antiphospholipid syndrome during a 10-year period: a multicentre prospective study of 1000 patients', Annals of the Rheumatic Diseases, bind 74, nr. 6, s. 1011-8. https://doi.org/10.1136/annrheumdis-2013-204838

@article{2890ef9d0f244a9eb2dd282a311db83d,

title = "Morbidity and mortality in the antiphospholipid syndrome during a 10-year period: a multicentre prospective study of 1000 patients",

abstract = "To assess the prevalence of the main causes of morbi-mortality in the antiphospholipid syndrome (APS) during a 10-year-follow-up period and to compare the frequency of early manifestations with those that appeared later.",

author = "R Cervera and R Serrano and Pons-Estel, \{G J\} and L Ceberio-Hualde and Y Shoenfeld and \{de Ram{\'o}n\}, E and V Buonaiuto and S{\o}ren Jacobsen and Zeher, \{M M\} and T Tarr and A Tincani and M Taglietti and G Theodossiades and E Nomikou and M Galeazzi and F Bellisai and Meroni, \{P L\} and Derksen, \{R H W M\} and \{de Groot\}, \{P G D\} and M Baleva and M Mosca and S Bombardieri and F Houssiau and J-C Gris and I Qu{\'e}r{\'e} and E Hachulla and C Vasconcelos and A Fern{\'a}ndez-Nebro and M Haro and Z Amoura and M Miyara and M Tektonidou and G Espinosa and Bertolaccini, \{M L\} and Khamashta, \{M A\} and \{on behalf of the Euro-Phospholipid Project Group (European Forum on Antiphospholipid Antibodies)\}",

year = "2015",

doi = "10.1136/annrheumdis-2013-204838",

language = "English",

volume = "74",

pages = "1011--8",

journal = "Annals of the Rheumatic Diseases",

issn = "0003-4967",

publisher = "Elsevier BV",

number = "6",

}

TY - JOUR

T1 - Morbidity and mortality in the antiphospholipid syndrome during a 10-year period

T2 - a multicentre prospective study of 1000 patients

AU - Cervera, R

AU - Serrano, R

AU - Pons-Estel, G J

AU - Ceberio-Hualde, L

AU - Shoenfeld, Y

AU - de Ramón, E

AU - Buonaiuto, V

AU - Jacobsen, Søren

AU - Zeher, M M

AU - Tarr, T

AU - Tincani, A

AU - Taglietti, M

AU - Theodossiades, G

AU - Nomikou, E

AU - Galeazzi, M

AU - Bellisai, F

AU - Meroni, P L

AU - Derksen, R H W M

AU - de Groot, P G D

AU - Baleva, M

AU - Mosca, M

AU - Bombardieri, S

AU - Houssiau, F

AU - Gris, J-C

AU - Quéré, I

AU - Hachulla, E

AU - Vasconcelos, C

AU - Fernández-Nebro, A

AU - Haro, M

AU - Amoura, Z

AU - Miyara, M

AU - Tektonidou, M

AU - Espinosa, G

AU - Bertolaccini, M L

AU - Khamashta, M A

AU - on behalf of the Euro-Phospholipid Project Group (European Forum on Antiphospholipid Antibodies)

PY - 2015

Y1 - 2015

N2 - To assess the prevalence of the main causes of morbi-mortality in the antiphospholipid syndrome (APS) during a 10-year-follow-up period and to compare the frequency of early manifestations with those that appeared later.

AB - To assess the prevalence of the main causes of morbi-mortality in the antiphospholipid syndrome (APS) during a 10-year-follow-up period and to compare the frequency of early manifestations with those that appeared later.

UR - https://www.scopus.com/pages/publications/84934930787

U2 - 10.1136/annrheumdis-2013-204838

DO - 10.1136/annrheumdis-2013-204838

M3 - Journal article

C2 - 24464962

SN - 0003-4967

VL - 74

SP - 1011

EP - 1018

JO - Annals of the Rheumatic Diseases

JF - Annals of the Rheumatic Diseases

IS - 6

ER -

Morbidity and mortality in the antiphospholipid syndrome during a 10-year period: a multicentre prospective study of 1000 patients

Abstract

Adgang til dokumentet

Andre filer og links

Fingeraftryk

Citationsformater